SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis
- 10 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 39 (27), 5015-5030
- https://doi.org/10.1038/s41388-020-1356-7
Abstract
Triple-negative breast cancer (TNBC) is extremely aggressive and lacks effective therapy. SAM and SH3 domain containing1 (SASH1) has been implicated in TNBC as a candidate tumor suppressor; however, the mechanisms of action of SASH1 in TNBC remain underexplored. Here, we show that SASH1 was significantly downregulated in TNBC patients samples compared with other subtypes of breast cancer. Ectopic SASH1 expression inhibited, while depletion of SASH1 enhanced, the invasive phenotype of TNBC cells, accompanied by deregulated expression of MMP2 and MMP9. The functional effects of SASH1 depletion were confirmed in the chicken chorioallantoic membrane and mouse xenograft models. Mechanistically, SASH1 knockdown downregulated the phosphorylation levels of the Hippo kinase LATS1 and its effector YAP (Yes associated protein), thereby upregulating YAP accumulation together with its downstream target CYR61. Consistently, forced SASH1 expression exhibited opposite effects. Pharmacological inhibition of YAP or knockdown of YAP reversed the enhanced cell invasion of TNBC cells following SASH1 depletion. Furthermore, SASH1-induced YAP signaling was LATS1-dependent, which in reverse enhanced phosphorylation of SASH1. The SASH1 S407A mutant (phosphorylation deficient) failed to rescue the altered YAP signaling by SASH1 knockdown. Notably, SASH1 depletion upregulated ARHGAP42 levels via YAP-TEAD and the YAP-ARHGAP42-actin axis contributed to SASH1-regulated TNBC cell invasion. Therefore, our findings uncover a new mechanism for the tumor-suppressive activity of SASH1 in TNBC, which may serve as a novel target for therapeutic intervention.Keywords
Funding Information
- National Natural Science Foundation of China (81772973, 81973646)
This publication has 39 references indexed in Scilit:
- Hippo pathway in mammary gland development and breast cancerActa Biochimica et Biophysica Sinica, 2014
- Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP–TEAD Protein–Protein InteractionACS Medicinal Chemistry Letters, 2014
- The Transcriptional Regulators TAZ and YAP Direct Transforming Growth Factor β-induced Tumorigenic Phenotypes in Breast Cancer CellsOnline Journal of Public Health Informatics, 2014
- Cytochalasin D acts as an inhibitor of the actin–cofilin interactionBiochemical and Biophysical Research Communications, 2012
- Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAPGenes & Development, 2012
- The candidate tumor suppressor SASH1 interacts with the actin cytoskeleton and stimulates cell–matrix adhesionThe International Journal of Biochemistry & Cell Biology, 2011
- The Hippo Transducer TAZ Confers Cancer Stem Cell-Related Traits on Breast Cancer CellsCell, 2011
- Ajuba LIM Proteins Are Negative Regulators of the Hippo Signaling PathwayCurrent Biology, 2010
- Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancerBritish Journal of Cancer, 2006
- Signaling from Rho to the Actin Cytoskeleton Through Protein Kinases ROCK and LIM-kinaseScience, 1999